文献速递炎症性肠病

综述:克罗恩病内瘘的检查与处理

Review article: investigation and management of internal fistulae in Crohn's disease.
PubMed 文献 · Aliment Pharmacol Ther · 2021-03-15

本文综述了克罗恩病内瘘的分类、诊断及内外科治疗,并提出治疗流程。内瘘在克罗恩病患者中发生率高达15%,诊断需内镜联合横断面影像(通常为磁共振),抗TNF治疗是内科治疗的主要手段,但许多患者仍需手术,多学科协作决策至关重要。

要点

  • 内瘘在克罗恩病患者中发生率高达15%,包括肠肠、肠结肠、肠膀胱及直肠阴道瘘。
  • 诊断需内镜联合横断面影像(通常为磁共振)以明确瘘管及病变范围。
  • 抗TNF药物是内科治疗主要手段,肠膀胱瘘数据较有前景,但许多患者仍需手术。

核心结论

  • 内瘘显著增加克罗恩病患者的发病率,需进一步研究确定结合内科与外科治疗的最佳多模式管理策略。

研究设计与样本

  • 对成人克罗恩病内瘘的文献进行综述、综合与总结。

主要发现

  • 内瘘在克罗恩病患者中发生率高达15%。
  • 诊断需内镜联合横断面影像(通常为磁共振)以明确瘘管及病变范围。
  • 抗TNF治疗是内科治疗的主要手段,肠膀胱瘘数据尤其有前景,但许多患者仍需手术。

关键数值与推荐

  • 内瘘在克罗恩病患者中发生率高达15%。
  • 诊断需内镜联合横断面影像,通常为磁共振。

临床怎么用

  • 内瘘诊断需结合内镜与横断面影像(通常为磁共振)评估瘘管及病变范围。
  • 抗TNF治疗作为内科主要手段,但手术指征与时机不确定,需多学科协作决策。

局限性

  • 关于内瘘的数据有限且质量普遍较低,多数研究聚焦于管腔疾病,内瘘结局报告较少。
  • 手术与内科治疗的最佳时机和指征仍不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Crohn's disease is an inflammatory, penetrating intestinal disease associated with fistula formation. Fistulae in Crohn's disease can be classified into external and internal fistulae. Internal fistulae form between the gastrointestinal tract and another internal organ and include enteroenteric, enterocolic, enterovesical and rectovaginal fistulae. They are associated with significant morbidity and a decreased quality of life. AIM: To review the classification, diagnosis, medical and surgical management of internal fistulae in Crohn's disease, and propose a treatment algorithm. METHODS: A literature review on internal fistulae in Crohn's disease in the adult population was undertaken, synthesised and summarised. RESULTS: Internal fistulae occur in up to 15% of patients with Crohn's disease. Multi-modal assessment including a combination of endoscopy and cross-sectional imaging, usually magnetic resonance, is required to diagnose fistulae and determine extent of disease. Determining optimal treatment strategies for these complex fistulae remains a challenge due to limited and generally low-quality data. Most studies to date have focussed on luminal disease, with (usually post hoc) outcomes more often reported for external fistulae, particularly perianal fistulae, than internal fistulae. Anti-tumour necrosis factor therapies have emerged as the mainstay of medical therapy, with particularly promising data for enterovesical fistulae, but many patients will still require surgical intervention. The indications and optimal timing of surgery vs medical therapy remains uncertain; thus multi-disciplinary input when making such decisions is important. CONCLUSIONS: Internal fistulae result in significantly increased morbidity in Crohn's disease, and further studies to determine optimal multi-modality management strategies incorporating medical and surgical therapy are required.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Tjandra D, Garg M, Behrenbruch C, et al. Review article: investigation and management of internal fistulae in Crohn's disease. Aliment Pharmacol Ther. 2021. PMID: 33721351. doi:10.1111/apt.16326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。